Overall Survival and Objective Response in Advanced Unresectable Hepatocellular Carcinoma: A Subanalysis of the REFLECT Study

Masatoshi Kudo; Richard S. Finn; Shukui Qin; Kwang–Hyub Han; Kenji Ikeda; Ann‐Lii Cheng; Francesco Tovoli; Kazuomi Ueshima; Hiroshi Aikata; Arndt Vogel; Carlos López; Marc Pracht; Zhiqiang Meng; Bruno Daniele; Joong-Won Park; Daniel H. Palmer; Corina E. Dutcus; Toshiyuki Tamai; Kenichi Saito; Riccardo Lencioni

doi:10.2139/ssrn.3523871

Article2022

Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

Masatoshi Kudo, Richard S. Finn, Shukui Qin, Kwang–Hyub Han, Kenji Ikeda, Ann‐Lii Cheng, Arndt Vogel, Francesco Tovoli, Kazuomi Ueshima, Hiroshi Aikata, Carlos López, Marc Pracht, Zhiqiang Meng, Bruno Daniele, Joong‐Won Park, D. Palmer, Toshiyuki Tamai, Kenichi Saito, Corina E. Dutcus, Riccardo Lencioni

Editorial Material2023

Objective Response to Systemic Therapy Is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma

Masatoshi Kudo

Article2019

Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT).

Masatoshi Kudo, Richard S. Finn, Shukui Qin, Kwang–Hyub Han, Kenji Ikeda, Ann‐Lii Cheng, Fabio Piscaglia, Kazuomi Ueshima, Hiroshi Aikata, Arndt Vogel, Carlos López, Marc Pracht, Zhiqiang Meng, Bruno Daniele, Joong‐Won Park, Daniel H. Palmer, Corina E. Dutcus, Toshiyuki Tamai, Kenichi Saito, Riccardo Lencioni

Article2021

Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies

Masatoshi Kudo, Robert Montal, Richard S. Finn, Florian Castet, Kazuomi Ueshima, Naoshi Nishida, Philipp K. Haber, Youyou Hu, Yasutaka Chiba, Myron Schwartz, Tim Meyer, Riccardo Lencioni, Josep M. Llovet

Clinical Cancer Research

Preprint2023

Data from Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies